Header Logo

Connection

MICHELE YORK to Humans

Back to Details
This is a "connection" page, showing publications MICHELE YORK has written about Humans.
MICHELE YORK
Connection Strength
0.531
Humans
  1. Neuroimaging correlates of cognitive stages in Parkinson's disease: A multimodal MRI study. Clin Neurol Neurosurg. 2026 05; 264:109343.
    View in: PubMed
    Score: 0.026
  2. Enough vs. More: Neuropsychological testing is more useful than genetic testing in the baseline evaluation of Parkinson disease. Parkinsonism Relat Disord. 2023 06; 111:105403.
    View in: PubMed
    Score: 0.021
  3. Developing a Culturally Competent Neuropsychological Battery for Diagnosis of Dementia in Arabic-Speaking Patients in the United States. Arch Clin Neuropsychol. 2023 Apr 26; 38(3):433-445.
    View in: PubMed
    Score: 0.021
  4. Culturally Competent Approaches for Neuropsychological Assessment for Differential Diagnosis of Dementia of Korean-Speaking Patients in the United States. Arch Clin Neuropsychol. 2023 Apr 26; 38(3):459-471.
    View in: PubMed
    Score: 0.021
  5. Developing a Culturally Competent Neuropsychological Assessment Battery for Vietnamese-speaking Patients with Suspected Dementia. Arch Clin Neuropsychol. 2023 Apr 26; 38(3):485-500.
    View in: PubMed
    Score: 0.021
  6. Development of standardized regression-based formulas to assess meaningful cognitive change in early Parkinson's disease. Arch Clin Neuropsychol. 2021 Jul 19; 36(5):734-745.
    View in: PubMed
    Score: 0.019
  7. The global pandemic has permanently changed the state of practice for pre-DBS neuropsychological evaluations. Parkinsonism Relat Disord. 2021 05; 86:135-138.
    View in: PubMed
    Score: 0.019
  8. A validation of a self-administered screening test for Parkinson's disease. J Neurol Sci. 2020 Nov 15; 418:117116.
    View in: PubMed
    Score: 0.018
  9. Predictors of rate of cognitive decline in patients with amnestic mild cognitive impairment. Clin Neuropsychol. 2022 01; 36(1):138-164.
    View in: PubMed
    Score: 0.017
  10. Benefit of phonemic cueing on confrontation naming in Alzheimer's disease. Clin Neuropsychol. 2020 02; 34(2):368-383.
    View in: PubMed
    Score: 0.016
  11. Performance Validity in Deep Brain Stimulation Candidates. Arch Clin Neuropsychol. 2018 Jun 01; 33(4):508-514.
    View in: PubMed
    Score: 0.015
  12. Comparative Patient Satisfaction and Feasibility of a Pilot Parkinson's Disease Enrichment Program. J Geriatr Psychiatry Neurol. 2017 Sep; 30(5):253-260.
    View in: PubMed
    Score: 0.014
  13. Alternating verbal fluency performance following bilateral subthalamic nucleus deep brain stimulation for Parkinson's disease. Eur J Neurol. 2012 Dec; 19(12):1525-31.
    View in: PubMed
    Score: 0.010
  14. The Rey 15-item memory test and Spanish-speaking older adults. Clin Neuropsychol. 2011 Oct; 25(7):1253-65.
    View in: PubMed
    Score: 0.010
  15. Changes in cognitive-emotional and physiological symptoms of depression following STN-DBS for the treatment of Parkinson's disease. Eur J Neurol. 2012 Jan; 19(1):121-7.
    View in: PubMed
    Score: 0.009
  16. Cognitive outcome and reliable change indices two years following bilateral subthalamic nucleus deep brain stimulation. Parkinsonism Relat Disord. 2011 Jun; 17(5):321-7.
    View in: PubMed
    Score: 0.009
  17. Frontal and temporal lobe involvement on verbal fluency measures in amyotrophic lateral sclerosis. J Clin Exp Neuropsychol. 2010 Nov; 32(9):913-22.
    View in: PubMed
    Score: 0.009
  18. Relationship between neuropsychological outcome and DBS surgical trajectory and electrode location. J Neurol Sci. 2009 Dec 15; 287(1-2):159-71.
    View in: PubMed
    Score: 0.008
  19. Five-year follow-up of unilateral posteroventral pallidotomy in Parkinson's disease. Surg Neurol. 2009 May; 71(5):551-8.
    View in: PubMed
    Score: 0.008
  20. Depressed mood and memory impairment before and after unilateral posteroventral pallidotomy in Parkinson's disease. J Neuropsychiatry Clin Neurosci. 2008; 20(3):357-63.
    View in: PubMed
    Score: 0.007
  21. Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry. 2008 Jul; 79(7):789-95.
    View in: PubMed
    Score: 0.007
  22. Short and long-term motor and cognitive outcome of staged bilateral pallidotomy: a retrospective analysis. Acta Neurochir (Wien). 2007; 149(9):857-66; discussion 866.
    View in: PubMed
    Score: 0.007
  23. Relative impact of multidomain lifestyle interventions on deficit accumulation frailty over 24 months in the U.S. POINTER trial. J Gerontol A Biol Sci Med Sci. 2026 Apr 07; 81(5).
    View in: PubMed
    Score: 0.007
  24. Cognitive reserve predicts baseline tau burden in the U.S. POINTER trial imaging cohort. Alzheimers Dement. 2025 11; 21(11):e70892.
    View in: PubMed
    Score: 0.006
  25. Cognitive Performance in Early Neuronal Synuclein Disease with Hyposmia but without Motor Disability: Association with Dopamine Deficiency and Isolated Rapid Eye Movement Sleep Behavior Disorder. Ann Neurol. 2025 09; 98(3):482-491.
    View in: PubMed
    Score: 0.006
  26. Baseline cognition and demographic, lifestyle, and cardiovascular risk factors in US POINTER. Alzheimers Dement. 2025 07; 21(7):e70216.
    View in: PubMed
    Score: 0.006
  27. Associations Between Deficit Accumulation Frailty and Baseline Markers of Lifestyle in the U.S. POINTER Trial. J Gerontol A Biol Sci Med Sci. 2025 01 16; 80(2).
    View in: PubMed
    Score: 0.006
  28. Use of Robust Norming to Create a Sensitive Cognitive Summary Score in De Novo Parkinson's Disease: An Illustrative Example. Mov Disord. 2025 Mar; 40(3):468-477.
    View in: PubMed
    Score: 0.006
  29. Long-Term Dementia Risk in Parkinson Disease. Neurology. 2024 09 10; 103(5):e209699.
    View in: PubMed
    Score: 0.006
  30. Delivering Multidisciplinary Rehabilitation Care in Parkinson's Disease: An International Consensus Statement. J Parkinsons Dis. 2024; 14(1):135-166.
    View in: PubMed
    Score: 0.006
  31. Geopolitical Considerations for Working with Medically Complex Patients: A Case Illustration. Arch Clin Neuropsychol. 2023 Apr 26; 38(3):387-394.
    View in: PubMed
    Score: 0.005
  32. A Neuropsychological Battery for the Evaluation of Dementia Among Mandarin-Speaking Older Adults in the United States. Arch Clin Neuropsychol. 2023 Apr 26; 38(3):446-458.
    View in: PubMed
    Score: 0.005
  33. Developing a Culturally Competent Neuropsychological Assessment Battery for Farsi-speaking Patients with Suspected Dementia. Arch Clin Neuropsychol. 2023 Apr 26; 38(3):472-484.
    View in: PubMed
    Score: 0.005
  34. Developing Culturally Competent Foreign Language Neuropsychological Assessments: Portuguese-Speaking Brazilians Living in the United States. Arch Clin Neuropsychol. 2023 Apr 26; 38(3):501-512.
    View in: PubMed
    Score: 0.005
  35. Seizure control and cognitive outcome after temporal lobectomy: a comparison of classic Ammon's horn sclerosis, atypical mesial temporal sclerosis, and tumoral pathologies. Epilepsia. 2003 Mar; 44(3):387-98.
    View in: PubMed
    Score: 0.005
  36. Clustering and switching in phonemic fluency following pallidotomy for the treatment of Parkinson's disease. J Clin Exp Neuropsychol. 2003 Feb; 25(1):110-21.
    View in: PubMed
    Score: 0.005
  37. Tele-Medicine Based and Self-Administered Interactive Exercise Program (Tele-Exergame) to Improve Cognition in Older Adults with Mild Cognitive Impairment or Dementia: A Feasibility, Acceptability, and Proof-of-Concept Study. Int J Environ Res Public Health. 2022 Dec 06; 19(23).
    View in: PubMed
    Score: 0.005
  38. Care4AD: A Technology-Driven Platform for Care Coordination and Management: Acceptability Study in Dementia. Gerontology. 2023; 69(2):227-238.
    View in: PubMed
    Score: 0.005
  39. Smart-Home Concept for Remote Monitoring of Instrumental Activities of Daily Living (IADL) in Older Adults with Cognitive Impairment: A Proof of Concept and Feasibility Study. Sensors (Basel). 2022 Sep 07; 22(18).
    View in: PubMed
    Score: 0.005
  40. Predictors of multi-domain cognitive decline following DBS for treatment of Parkinson's disease. Parkinsonism Relat Disord. 2022 02; 95:23-27.
    View in: PubMed
    Score: 0.005
  41. North American survey on impact of the COVID-19 pandemic shutdown on DBS care. Parkinsonism Relat Disord. 2021 11; 92:41-45.
    View in: PubMed
    Score: 0.005
  42. Verbal working memory storage and processing deficits in HIV-1 asymptomatic and symptomatic individuals. Psychol Med. 2001 Oct; 31(7):1279-91.
    View in: PubMed
    Score: 0.005
  43. Assessment of deep brain stimulation candidacy during the COVID-19 pandemic: Lessons learned and future directions for neuropsychologists. Clin Neuropsychol. 2022 01; 36(1):72-84.
    View in: PubMed
    Score: 0.005
  44. Digital Biomarkers of Cognitive Frailty: The Value of Detailed Gait Assessment Beyond Gait Speed. Gerontology. 2022; 68(2):224-233.
    View in: PubMed
    Score: 0.005
  45. Pallidotomy and psychological outcomes. J Neurosurg. 2001 May; 94(5):866-8.
    View in: PubMed
    Score: 0.005
  46. Decrease in Mobility during the COVID-19 Pandemic and Its Association with Increase in Depression among Older Adults: A Longitudinal Remote Mobility Monitoring Using a Wearable Sensor. Sensors (Basel). 2021 Apr 29; 21(9).
    View in: PubMed
    Score: 0.005
  47. Exercise interventions for older adults with Alzheimer's disease: a systematic review and meta-analysis protocol. Syst Rev. 2021 01 04; 10(1):6.
    View in: PubMed
    Score: 0.005
  48. Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson disease. Ann Clin Transl Neurol. 2020 04; 7(4):449-461.
    View in: PubMed
    Score: 0.004
  49. Acute readmission following deep brain stimulation surgery for Parkinson's disease: A nationwide analysis. Parkinsonism Relat Disord. 2020 01; 70:96-102.
    View in: PubMed
    Score: 0.004
  50. Neuropsychological outcome following unilateral pallidotomy. Brain. 1999 Dec; 122 ( Pt 12):2209-20.
    View in: PubMed
    Score: 0.004
  51. A Guide to Understanding the Benefits of a Multidisciplinary Team Approach to Amyotrophic Lateral Sclerosis (ALS) Treatment. Arch Phys Med Rehabil. 2019 03; 100(3):583-586.
    View in: PubMed
    Score: 0.004
  52. Pseudobulbar Affect Correlates With Mood Symptoms in Parkinsonian Disorders but Not Amyotrophic Lateral Sclerosis. J Neuropsychiatry Clin Neurosci. 2018; 30(3):214-219.
    View in: PubMed
    Score: 0.004
  53. Leg stereotypy syndrome: phenomenology and prevalence. J Neurol Neurosurg Psychiatry. 2018 07; 89(7):692-695.
    View in: PubMed
    Score: 0.004
  54. Physical Activity Recommendations for the Aging Brain: A Clinician-Patient Guide. Arch Phys Med Rehabil. 2016 06; 97(6):1045-7.
    View in: PubMed
    Score: 0.003
  55. Acute and Long-Term Effects of Multidirectional Treadmill Training on Gait and Balance in Parkinson Disease. PM R. 2016 12; 8(12):1151-1158.
    View in: PubMed
    Score: 0.003
  56. Skin irritation testing in man for hazard assessment--evaluation of four patch systems. Hum Exp Toxicol. 1995 Sep; 14(9):729-34.
    View in: PubMed
    Score: 0.003
  57. Neurocognitive deficits increase risk of poor retention in care among older adults with newly diagnosed HIV infection. AIDS. 2015 Aug 24; 29(13):1711-4.
    View in: PubMed
    Score: 0.003
  58. A Pilot Study of a Cognitive-Behavioral Treatment for Anxiety and Depression in Patients With Parkinson Disease. J Geriatr Psychiatry Neurol. 2015 Sep; 28(3):210-7.
    View in: PubMed
    Score: 0.003
  59. Neuropsychological changes following deep brain stimulation surgery for Parkinson's disease: comparisons of treatment at pallidal and subthalamic targets versus best medical therapy. J Neurol Neurosurg Psychiatry. 2015 Jun; 86(6):622-9.
    View in: PubMed
    Score: 0.003
  60. Impulsive and compulsive behaviors in Parkinson Study Group (PSG) centers performing deep brain stimulation surgery. J Parkinsons Dis. 2014; 4(4):591-8.
    View in: PubMed
    Score: 0.003
  61. TM4SF20 ancestral deletion and susceptibility to a pediatric disorder of early language delay and cerebral white matter hyperintensities. Am J Hum Genet. 2013 Aug 08; 93(2):197-210.
    View in: PubMed
    Score: 0.003
  62. Influence of socio-demographic characteristics on DRS-2 performance in Spanish-speaking older adults. Arch Clin Neuropsychol. 2012 Aug; 27(5):545-56.
    View in: PubMed
    Score: 0.003
  63. Assessment of appropriate medication administration for hospitalized patients with Parkinson's disease. Parkinsonism Relat Disord. 2012 May; 18(4):377-81.
    View in: PubMed
    Score: 0.002
  64. Cognitive behavioral therapy for depression and anxiety in Parkinson's disease: a clinical review. J Parkinsons Dis. 2012; 2(2):135-51.
    View in: PubMed
    Score: 0.002
  65. The prevalence of symptomatic orthostatic hypotension in patients with Parkinson's disease and atypical parkinsonism. Parkinsonism Relat Disord. 2011 Sep; 17(8):625-8.
    View in: PubMed
    Score: 0.002
  66. Does apolipoprotein E genotype modify the clinical expression of ALS? Eur J Neurol. 2011 Apr; 18(4):618-24.
    View in: PubMed
    Score: 0.002
  67. A decrease in body mass index is associated with faster progression of motor symptoms and shorter survival in ALS. Amyotroph Lateral Scler. 2010 Dec; 11(6):542-8.
    View in: PubMed
    Score: 0.002
  68. Improvement of neurological symptoms and memory and emotional status in a case of seronegative Sneddon syndrome with cyclophosphamide. Clin Neurol Neurosurg. 2010 Jul; 112(6):544-7.
    View in: PubMed
    Score: 0.002
  69. Detecting frontotemporal dysfunction in ALS: utility of the ALS Cognitive Behavioral Screen (ALS-CBS). Amyotroph Lateral Scler. 2010 May 03; 11(3):303-11.
    View in: PubMed
    Score: 0.002
  70. Differences between clinical subspecialties in the outpatient evaluation and treatment of dementia in an academic medical center. Dement Geriatr Cogn Disord. 2010; 29(1):28-36.
    View in: PubMed
    Score: 0.002
  71. ALS disease onset may occur later in patients with pre-morbid diabetes mellitus. Eur J Neurol. 2010 May; 17(5):733-9.
    View in: PubMed
    Score: 0.002
  72. Ethnic disparities in the treatment of dementia in veterans. Dement Geriatr Cogn Disord. 2009; 28(2):145-52.
    View in: PubMed
    Score: 0.002
  73. Predictors of individual visual memory decline after unilateral anterior temporal lobe resection. Neurology. 2009 May 26; 72(21):1837-42.
    View in: PubMed
    Score: 0.002
  74. Lumbar puncture alleviates chorea in a patient with Huntington's disease and normal pressure hydrocephalus. Behav Neurol. 2009; 21(3):193-5.
    View in: PubMed
    Score: 0.002
  75. Changes in individual and group spatial and verbal learning characteristics after anterior temporal lobectomy. Epilepsia. 2009 Jun; 50(6):1385-95.
    View in: PubMed
    Score: 0.002
  76. Memory, emotional and vocational impairments before and after anterior temporal lobectomy for complex partial seizures. Epilepsia. 2006 Nov; 47(11):1922-30.
    View in: PubMed
    Score: 0.002
  77. The neural substrates of reward processing in humans: the modern role of FMRI. Neuroscientist. 2004 Jun; 10(3):260-8.
    View in: PubMed
    Score: 0.001
  78. Neuropsychological outcome after unilateral pallidotomy for the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry. 2000 Sep; 69(3):326-36.
    View in: PubMed
    Score: 0.001
  79. Stereotactic pallidotomy for the treatment of Parkinson's disease. Efficacy and adverse effects at 6 months in 26 patients. Neurology. 1998 Feb; 50(2):434-8.
    View in: PubMed
    Score: 0.001
  80. Interlaboratory evaluation of a human patch test for the identification of skin irritation potential/hazard. Food Chem Toxicol. 1997 Feb; 35(2):255-60.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.